Corrigendum to "Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells" [Biochem. Pharmacol. 93 (3) (2015) 290-304]
Biochem Pharmacol. 2020 May:175:113810.
doi: 10.1016/j.bcp.2020.113810.
Epub 2020 Feb 19.
1 Cell Death Research and Therapy Unit, Department for Cellular and Molecular Medicine, University of Leuven (KU Leuven), Campus Gasthuisberg, O&N1, Herestraat 49, Box 802, 3000 Leuven, Belgium.
2 Laboratory of Lipid Metabolism and Cancer, Department of Oncology, University of Leuven (KU Leuven), Campus Gasthuisberg, O&N1, Herestraat 49, Box 818, 3000 Leuven, Belgium.
3 Cell Death Research and Therapy Unit, Department for Cellular and Molecular Medicine, University of Leuven (KU Leuven), Campus Gasthuisberg, O&N1, Herestraat 49, Box 802, 3000 Leuven, Belgium. Electronic address: [email protected].